Unplanned PCI post TAVI is uncommon, and the incidence decreases over time. In the first two years following TAVI, acute coronary syndrome is the primary rationale for PCI; thereafter, chronic coronary syndromes are more common. Balloon-expandable and self-expandable bioprostheses appear to have no differences in the frequency or success of unplanned PCIs after TAVR. Hardware’s […]
PCI Post TAVI with Core Valve Read More »
Following TAVI, coronary interventions can be technically challenging. The selective cannulation of the coronary ostia, which is dependent on patient anatomy, valve type and design, and implantation parameters including implantation depth and the orientation of the commissural tabs with respect to the ostia, is the most difficult part of the surgery. The following, we summarise
Coronary Angiogram Protocols Post TAVI With Core Valve Read More »
The prevalence of coronary artery disease in patients with severe aortic stenosis undergoing TAVI ranges from 40% to 75%. According to single-center studies, between 3.5% and 5.7% of TAVI patients required PCI after TAVI. “As the indication for TAVR expands to lower risk patients with a better long-term prognosis, the need for repeat coronary angiography and
How can coronary access be improved after TAVI? Read More »
Since the first reports of percutaneous catheter therapy for atrial fibrillation (AF) were published exactly twenty years ago, the field has grown exponentially. The current standard of care, which has evolved through many techniques and treatment plans, entails pulmonary vein isolation (PVI) using Radio-frequency (RF) or other energy sources. While it has been demonstrated that
3-Dimensional Rotational Angiography an Imaging Tool in Atrial Fibrillation Ablation Read More »
QFR and OFR in the Assessment of intermediate CAD that may benefit from percutaneous coronary intervention, a physiological lesion assessment is indicated. The optical flow ratio (OFR) is a more modern approach for the quick and automated assessment of coronary physiology from intracoronary optical coherence tomography (OCT). The quantitative flow ratio (QFR) was created to
QFR and OFR In the Assessment of Intermediate CAD Read More »
The use of a transcatheter device to congenital Ventricular Septal Defect Closure Is an appealing and practical alternative to surgery. Isolated congenital VSDs are the most prevalent type of congenital heart disease in children and babies, accounting for 25–35 percent of all cardiac abnormalities. The majority of VSDs are found in the ventricular septum’s membranous
Ventricular Septal Defect Closure Read More »
ASD Device closure is an Interventional treatment to close the congenital atrial septal defect (ASD) in heart. An atrial septal defect (ASD) is an abnormal opening in the wall (septum) between heart two upper chambers named atria. Every baby is born with a small opening there. The hole usually closes a few weeks or months
Cathlab Protocols: ASD Device Closure Read More »
Balloon Mitral Valvuloplasty is an Interventional treatment used to increase the opening of a narrowed (stenotic) valve The most common cause of native mitral stenosis is rheumatic heart disease. The obstruction to inflow resulting from fusion of the valve commissures is the pathophysiologic problem in these patients. Left atrial hypertension, atrial arrhythmias, pulmonary hypertension, and
Cathlab Protocols: Balloon Mitral Valvuloplasty (BMV) Read More »
Diagnostic cardiac catheterization is the procedure of inserting catheters, which are hollow plastic tubes with a diameter of 2 to 3 mm, into veins and/or arteries in the neck, leg, or arm, and then advancing them to the right and left sides of the heart. The pressure of the blood in various chambers of the
Protocols For Diagnostic Cardiac Catheterization Read More »
Cardiovascular disease is one of the primary causes of death in industrialised countries and is one of the leading causes of death World wide. Coronary artery disease (CAD) is among the leading causes of heart Disease and stroke, accounting for 60% to 70% of myocardial infarctions (MIs) and 50% to 80% of deaths from heart
Percutaneous Transluminal Coronary Angioplasty Read More »
